Pharmacological interventions for chronic pain in children: an overview of systematic reviews
- PMID: 31335640
- DOI: 10.1097/j.pain.0000000000001609
Pharmacological interventions for chronic pain in children: an overview of systematic reviews
Abstract
We know little about the safety or efficacy of pharmacological medicines for children and adolescents with chronic pain, despite their common use. Our aim was to conduct an overview review of systematic reviews of pharmacological interventions that purport to reduce pain in children with chronic noncancer pain (CNCP) or chronic cancer-related pain (CCRP). We searched the Cochrane Database of Systematic Reviews, Medline, EMBASE, and DARE for systematic reviews from inception to March 2018. We conducted reference and citation searches of included reviews. We included children (0-18 years of age) with CNCP or CCRP. We extracted the review characteristics and primary outcomes of ≥30% participant-reported pain relief and patient global impression of change. We sifted 704 abstracts and included 23 systematic reviews investigating children with CNCP or CCRP. Seven of those 23 reviews included 6 trials that involved children with CNCP. There were no randomised controlled trials in reviews relating to reducing pain in CCRP. We were unable to combine data in a meta-analysis. Overall, the quality of evidence was very low, and we have very little confidence in the effect estimates. The state of evidence of randomized controlled trials in this field is poor; we have no evidence from randomised controlled trials for pharmacological interventions in children with cancer-related pain, yet cannot deny individual children access to potential pain relief. Prospero ID: CRD42018086900.
Comment in
-
Pain relief in children and adolescents.Pain. 2019 Aug;160(8):1687-1688. doi: 10.1097/j.pain.0000000000001613. Pain. 2019. PMID: 31335636 No abstract available.
-
Clinical management in an evidence vacuum: pharmacological management of children with persistent pain.Cochrane Database Syst Rev. 2019 Jun 26;6(6):ED000135. doi: 10.1002/14651858.ED000135. Cochrane Database Syst Rev. 2019. PMID: 31390043 Free PMC article. No abstract available.
References
-
- Adachi N, Munesada M, Yamada N, Suzuki H, Futohashi A, Shigeeda T, Kato S, Nishigaki M. Effects of aromatherapy massage on face-down posture-related pain after vitrectomy: a randomized controlled trial. Pain Manag Nurs 2014;15:482–9.
-
- Arnold LM, Schikler KN, Bateman L, Khan T, Pauer L, Bhadra-Brown P, Clair A, Chew ML, Scavone J; Group PAFS. Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study. Pediatr Rheumatol Online J 2016;14:46.
-
- Asgarshirazi M, Shariat M, Dalili H. Comparison of the effects of pH-dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo controlled study. Iran Red Crescent Med J 2015;17:e23844.
-
- Bahar RJ, Collins BS, Steinmetz B, Ament ME. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr 2008;152:685–9.
-
- Bao YJ, Hou W, Kong XY, Yang L, Xia J, Hua BJ, Knaggs R. Hydromorphone for cancer pain. Cochrane Database Syst Rev 2016;CD011108.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
